Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Emidio Scarpellini, Lucrezia Laterza, Gianluca Ianiro, Jan Tack, Ludovico Abenavoli & Antonio Gasbarrini. (2016) Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 17:10, pages 1395-1402.
Read now
Read now
Articles from other publishers (21)
Jiayi Chen, Xiaoji Zhu, Yang Peng, Huirong Liu, Huangan Wu & Cili Zhou. (2023) Effects of moxibustion on behaviors and tryptophan metabolism-related products in mice with irritable bowel syndrome艾灸对肠易激综合征小鼠行为学及色氨酸代谢相关产物的影响. Journal of Acupuncture and Tuina Science 21:2, pages 91-100.
Crossref
Crossref
Ali Akbari & Muhammad Saleh Faryabi. (2023) A New Method for the Synthesis of 1-Methyl-1H-indole-3-carboxylate Derivatives, Employing Copper(II). Synthesis.
Crossref
Crossref
Toshiyuki Hikita, Hideki Hoshino & Masakazu Mimaki. (2020) Ramosetron as a Treatment for Cyclic Vomiting Syndrome: A Small-Scale Patient Trial. Global Pediatric Health 7, pages 2333794X2096928.
Crossref
Crossref
Rui Fu, Mingxian Chen, Yu Chen, Guoqun Mao & Saiyue Liu. (2019) Expression and clinical significance of 5‑HT and 5‑HT3R in the intestinal mucosa of patient with diarrhea‑type irritable bowel syndrome. Experimental and Therapeutic Medicine.
Crossref
Crossref
Y. Kawahara, K. Mitsui, T. Niwa, N. Morimoto, S. Kawaharada & S. Katsumata. (2018) Translocator protein 18kDa antagonist ameliorates stress-induced stool abnormality and abdominal pain in rodent stress models. Neurogastroenterology & Motility 30:11, pages e13425.
Crossref
Crossref
Orla Craig. (2018) New therapies in Irritable Bowel Syndrome. Current Opinion in Gastroenterology 34:1, pages 50-56.
Crossref
Crossref
James J. LynchIIIIII, Terry R. Van Vleet, Scott W. Mittelstadt & Eric A.G. Blomme. (2017) Potential functional and pathological side effects related to off-target pharmacological activity. Journal of Pharmacological and Toxicological Methods 87, pages 108-126.
Crossref
Crossref
Banghyun Lee, Kidong Kim, Dong Hoon Suh, Hyun-Jung Shin, Jae Hong No, Jung Ryeol Lee, Byung Chul Jee, Jung Won Hwang, Sang Hwan Do & Yong Beom Kim. (2017) Efficacy of Single-dose and 2-dose Intravenous Administration of Ramosetron in Preventing Postoperative Nausea and Vomiting After Laparoscopic Gynecologic Operation: A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 27:3, pages 183-188.
Crossref
Crossref
Yongping Zheng, Ting Yu, Yurong Tang, Wenjie Xiong, Xiaoxue Shen, Ling Jiang & Lin Lin. (2017) Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. PLOS ONE 12:3, pages e0172846.
Crossref
Crossref
Susan Lucak, Lin Chang, Albena Halpert & Lucinda A. Harris. (2016) Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therapeutic Advances in Gastroenterology 10:2, pages 253-275.
Crossref
Crossref
Isabel Vera & F. Javier Júdez. (2017) Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Maciej Sałaga & Paula Mosińska. 2017. Introduction to Gastrointestinal Diseases Vol. 1. Introduction to Gastrointestinal Diseases Vol. 1
43
61
.
Shin Fukudo, Yoshikazu Kinoshita, Toshikatsu Okumura, Motoko Ida, Kenta Hayashi, Hiraku Akiho, Yoshihiro Nakashima & Ken Haruma. (2016) Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study. Journal of Gastroenterology 51:9, pages 874-882.
Crossref
Crossref
Michael Camilleri, Lionel Buéno, Viola Andresen, Fabrizio De Ponti, Myung-Gyu Choi & Anthony Lembo. (2016) Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders. Gastroenterology 150:6, pages 1319-1331.e20.
Crossref
Crossref
Cheng Yang, Ying Xiong, Sheng-Sheng Zhang, Fang-Mei An, Jing Sun, Qing-Lin Zhang & Qiang Zhan. (2016)
Regulating effect of TongXie-YaoFang on colonic epithelial secretion
via
Cl
-
and HCO
3
-
channel
. World Journal of Gastroenterology 22:48, pages 10584.
Crossref
Crossref
Robin Spiller. (2016) Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Research 5, pages 780.
Crossref
Crossref
Jan Tack, Tim Vanuytsel & Maura Corsetti. (2016) Modern Management of Irritable Bowel Syndrome: More Than Motility. Digestive Diseases 34:5, pages 566-573.
Crossref
Crossref
Akhilesh Wadhwa, Michael Camilleri & Madhusudan Grover. (2015) New and Investigational Agents for Irritable Bowel Syndrome. Current Gastroenterology Reports 17:12.
Crossref
Crossref
Tim Vanuytsel, Jan F. Tack & Guy E. Boeckxstaens. (2014) Treatment of abdominal pain in irritable bowel syndrome. Journal of Gastroenterology 49:8, pages 1193-1205.
Crossref
Crossref
Madhusudan Grover & Michael Camilleri. (2014) Ramosetron in Irritable Bowel Syndrome With Diarrhea: New Hope or the Same Old Story?. Clinical Gastroenterology and Hepatology 12:6, pages 960-962.
Crossref
Crossref
Yu Chen, Ai-qin Chen, Xiao-qing Luo, Li-xia Guo, Ying Tang, Cheng-jia Bao, Ling Lin & Chun Lin. (2014) Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain. Brain Research 1570, pages 43-53.
Crossref
Crossref